PTC Therapeutics, Inc.
Follow $PTCT
One email when a member of Congress discloses a trade in it, with the official filing receipt linked.
Free. No account. Unsubscribe in one click.
Follow $PTCT by emailVeridion Score
BETALOW CONF · 6 of 6 factors measuredsnapshot unavailable for PTCT. Cause unavailable.
Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Why is PTCT moving today?
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
PTCT overview
Related filings and maps
Congress activity in PTCT
No receipt-qualified Congressional disclosure is present for PTCT in the cached public ledger.
PTCT contract awards, year to date.
Public federal awards linked to this ticker.
PTCT lobbying filings, year to date.
Registered lobbying filings matched to PTC Therapeutics, Inc..